U.S. lawmakers unlikely to get answers from ex-drug executive Shkreli

NEW YORK/WASHINGTON, Feb 4 (Reuters) - Martin Shkreli, the former drug executive who raised the price of a lifesaving medicine by 5,000 percent, is set to appear as a witness at a congressional hearing on Thursday but is unlikely to answer lawmakers' questions about price spikes.